ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $325,573 | -18.8% | 59,738 | 0.0% | 0.06% | 0.0% |
Q2 2023 | $400,842 | -24.0% | 59,738 | 0.0% | 0.06% | -27.3% |
Q1 2023 | $527,487 | +15.6% | 59,738 | 0.0% | 0.08% | +6.9% |
Q4 2022 | $456,398 | +7.1% | 59,738 | -0.2% | 0.07% | -6.5% |
Q3 2022 | $426,000 | -12.0% | 59,851 | 0.0% | 0.08% | -28.0% |
Q2 2022 | $484,000 | -41.1% | 59,851 | +1.0% | 0.11% | -33.1% |
Q1 2022 | $822,000 | -50.5% | 59,238 | +0.2% | 0.16% | -52.5% |
Q4 2021 | $1,659,000 | -17.5% | 59,138 | 0.0% | 0.34% | -29.1% |
Q3 2021 | $2,010,000 | -16.8% | 59,138 | 0.0% | 0.48% | -20.7% |
Q2 2021 | $2,416,000 | +1.5% | 59,138 | 0.0% | 0.60% | +1.4% |
Q1 2021 | $2,381,000 | -31.9% | 59,138 | 0.0% | 0.59% | -57.8% |
Q4 2020 | $3,497,000 | -5.4% | 59,138 | -22.2% | 1.40% | -19.3% |
Q3 2020 | $3,696,000 | -6.2% | 76,008 | -6.6% | 1.73% | -9.9% |
Q2 2020 | $3,939,000 | +52.4% | 81,418 | -12.5% | 1.92% | +24.8% |
Q1 2020 | $2,584,000 | – | 93,000 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |